Transaction details

Ethica Corporate Finance advised Biologici Italia Laboratories in the acquisition of Liosintex

Ethica Corporate Finance advised Biologici Italia Laboratories in the acquisition of Liosintex, a company active in the lyophilisation of sterile antibiotics in bulk for the pharmaceutical industry.

Biological Italy Laboratories, a company based in Milan, produces injectable products for acute hospitalization in various therapeutic areas.